Nivolumab Shows Significant Overall Survival Benefit in Metastatic Gastric Cancer - 101967

Spotlight
Video

Nivolumab Shows Significant Overall Survival Benefit in Metastatic Gastric Cancer

Loading........
Description: Ian Chau, MD, FRCP of Royal Marsden Hospital discusses how Nivolumab Shows Significant Overall Survival Benefit in Metastatic Gastric Cancer at ASCO GI 2017
Shared By : Gastrointestinal-Cancer-Meeting
Posted on : 01/24/17
Added : 1 year ago



Recommended

Nothing found.

More From Gastrointestinal-Cancer-Meet...

Nothing found.